Stephan Karl ZAHN,Guido BOEHMELT,Andreas MANTOULIDIS,Ulrich REISER,Matthias TREU,Ulrich GUERTLER,Andreas SCHOOP,Flavio SOLCA,Ulrike TONTSCH-GRUNT,Ralph BRUECKNER,Charlotte REITHER,Lars HERFURTH,Oliver
申请号：
US13850711
公开号：
US20130281429A1
申请日:
2013.03.26
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention encompasses compounds of general formula (1)whereinR1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.
